Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07763158
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent Pain in Patients With Severe Knee OsteoarthritisKing Abdullah International Medical Research CenterRecruitingNot Applicable
NCT07763158Recruiting
Not Applicable
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent...King Abdullah Internation...
NCT07763444
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan UniversityCompletedNot Applicable
NCT07763444Completed
Not Applicable
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan Univers...
NCT07763821
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Assiut UniversityNot Yet Recruiting
NCT07763821Not Yet Recruiting
—
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephrit...Assiut University
NCT07762157
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute ExacerbationNorth District HospitalRecruitingNot Applicable
NCT07762157Recruiting
Not Applicable
The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chroni...North District Hospital
NCT07762898
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and FrailtyGansu University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07762898Not Yet Recruiting
Not Applicable
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and...Gansu University of Chine...
NCT07763782
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervised Home WalksMTI UniversityNot Yet RecruitingNot Applicable
NCT07763782Not Yet Recruiting
Not Applicable
Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervi...MTI University
NCT07764185
Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseasePhotozig, Inc.Not Yet RecruitingPhase 2
NCT07764185Not Yet Recruiting
Phase 2
Caring Recharge Project for Caregivers of Individuals With Alzheimer's DiseasePhotozig, Inc.
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762222
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous UlcersAin Shams UniversityRecruitingNot Applicable
NCT07762222Recruiting
Not Applicable
Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chr...Ain Shams University
NCT07763704
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut UniversityNot Yet Recruiting
NCT07763704Not Yet Recruiting
—
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut University
NCT07762612
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Improve Engagement in Care Among Sexual Minority Men Living With HIV in JamaicaNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07762612Not Yet Recruiting
Not Applicable
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Impr...National Institute of Men...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07762027
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionAssembly BiosciencesNot Yet RecruitingPhase 2
NCT07762027Not Yet Recruiting
Phase 2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Part...Assembly Biosciences
NCT07762586
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Rutgers, The State University of New JerseyRecruitingPhase 2
NCT07762586Recruiting
Phase 2
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NA...Rutgers, The State Univer...
NCT07764172
Sarcopenia in Acute Ischemic StrokeUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)Recruiting
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07763743
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy With Vacuum-Assisted Access SheathAin Shams UniversityRecruitingNot Applicable
NCT07763743Recruiting
Not Applicable
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ure...Ain Shams University
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting7 (35%)
Completed2 (10%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 31 (5%)
Phase 41 (5%)
Phase 11 (5%)